Published in Int J Cell Biol on December 19, 2011
Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev (2016) 0.79
Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression. Oncotarget (2015) 0.78
Low temperature mitigates cardia bifida in zebrafish embryos. PLoS One (2013) 0.75
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87
Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol (2006) 7.20
Anoikis mechanisms. Curr Opin Cell Biol (2001) 6.36
Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol (2002) 4.23
Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood (1999) 4.13
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med (2009) 3.87
Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol (1998) 3.52
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med (2003) 3.33
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol (2001) 2.99
The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest (2001) 2.55
Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature (1991) 2.53
Platelet-derived growth factor receptor signals. J Biol Chem (1994) 2.41
Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol (2000) 2.21
A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. J Cell Biol (1987) 1.88
Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood (1998) 1.55
Real time analysis of the affinity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affinity between resting and Mn(2+) or antibody activation. J Biol Chem (2001) 1.51
Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development. J Cell Biol (2007) 1.35
Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med (1995) 1.33
Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood (1998) 1.28
Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev (2001) 1.26
Loss of attachment to fibronectin with terminal human erythroid differentiation. Blood (1990) 1.26
Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol (1997) 1.25
Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood (2000) 1.21
Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem (1995) 1.19
VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest (1998) 1.17
Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest (1995) 1.13
Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia. Leukemia (2007) 1.13
Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl. Proc Natl Acad Sci U S A (2003) 1.12
Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol (2007) 1.11
Dual role of fibronectin in hematopoietic differentiation. Blood (1989) 1.11
The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance. Curr Opin Oncol (2000) 1.09
Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2010) 1.08
Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ (2001) 1.08
Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer (2003) 1.07
A critical role of VLA-4 in erythropoiesis in vivo. Blood (1996) 1.07
Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J Immunol (1999) 1.06
Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts. Blood (1988) 1.05
Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk Lymphoma (1995) 1.03
A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. J Biol Chem (2007) 1.02
Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J Exp Med (1994) 0.98
Cell adhesion in the stromal regulation of haemopoiesis. Baillieres Clin Haematol (1992) 0.97
Morphological study of the transition of haematopoietic sites in the developing mouse during the peri-natal period. Anat Histol Embryol (2006) 0.96
From anchorage dependent proliferation to survival: lessons from redox signalling. IUBMB Life (2008) 0.94
Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly. Biochemistry (2002) 0.93
Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues. Am J Pathol (1993) 0.93
Roles for integrin very late activation antigen-4 in stroma-dependent erythropoiesis. Blood (1994) 0.93
Molecular interactions between human B-cell progenitors and the bone marrow microenvironment. Exp Cell Res (1996) 0.89
Integrin agonists as adjuvants in chemotherapy for melanoma. Clin Cancer Res (2008) 0.88
Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res (2003) 0.87
Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells. Cell Growth Differ (1998) 0.87
Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun (2001) 0.87
Role of ERK activation in growth and erythroid differentiation of K562 cells. Exp Cell Res (2001) 0.86
Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin. Biochemistry (2000) 0.86
The adventures of a biologist: prenatal diagnosis, hematopoiesis, leukemia, carcinogenesis, and tumor suppression. Adv Cancer Res (1995) 0.85
VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression. J Biol Chem (2009) 0.84
Up-regulation of VLA-5 expression during monocytic differentiation and its role in negative control of the survival of peripheral blood monocytes. J Immunol (1996) 0.83
Adherence of human erythroleukemia cells inhibits proliferation without inducing differentiation. Cell Growth Differ (2000) 0.83
Identification of tenascin-C as a key molecule determining stromal cell-dependent erythropoiesis. Exp Hematol (2006) 0.82
Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation. J Cell Biochem (2007) 0.82
Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin. J Biochem (1997) 0.81
Expression of tenascin in developing and adult mouse lymphoid organs. J Histochem Cytochem (1993) 0.81
Molecular analysis of the hematopoietic microenvironment. Pediatr Res (1994) 0.78
Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4. J Biol Chem (2009) 0.78
An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J Immunol (2004) 1.66
Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials (2005) 1.62
A role for IL-27 in early regulation of Th1 differentiation. J Immunol (2005) 1.45
IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol (2006) 1.34
Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering. Biomaterials (2010) 1.25
IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J Immunol (2006) 1.15
Induction of IgG2a class switching in B cells by IL-27. J Immunol (2004) 1.07
A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. J Biol Chem (2007) 1.02
STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production. J Immunol (2008) 1.01
Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly. Biochemistry (2002) 0.93
A new type of antimetastatic peptide derived from fibronectin. Clin Cancer Res (2002) 0.90
VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression. J Biol Chem (2009) 0.84
Antiadhesive sites present in the fibronectin type III-like repeats of human plasma fibronectin. Biol Pharm Bull (2007) 0.81
Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins. Biol Pharm Bull (2008) 0.81
Eukaryotic translation elongation factor 1A induces anoikis by triggering cell detachment. J Biol Chem (2012) 0.80
Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation. Ann Hematol (2012) 0.80
A novel mechanism underlying the basic defensive response of macrophages against Mycobacterium infection. J Immunol (2014) 0.78
Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4. J Biol Chem (2009) 0.78
Nectin-3 expression is elevated in limbal epithelial side population cells with strongly expressed stem cell markers. Biochem Biophys Res Commun (2009) 0.77
The cell adhesion and proliferation activities of a peptide derived from human tenascin-C are dependent on two Ile residues. Bioorg Med Chem (2012) 0.75
Control of cell adhesion and proliferation utilizing polysaccharide composite film scaffolds. Colloids Surf B Biointerfaces (2017) 0.75
A fibronectin fragment induces tumor necrosis factor production of rat basophilic leukemia cells. Biochim Biophys Acta (2004) 0.75
Milk growth factor (MGF) induces transformation into ATDC5 cells, prechondrocytes, and cooperates with retinoic acid to transform the cells into new forms. Life Sci (2005) 0.75